Table of Contents

All the data and content are powered by ZXData, Learn more about ZXData

ZX Data private stock trade

Executive Summary

  • This quarter, reporting holders marked up their private portfolios by 20.9% ($ weighted), the highest in over 5 years and mainly driven by large exposure to SpaceX across multiple funds.
  • Sentiment up:
  • Sentiment down:
  • In February, 27% of companies with ZX Index Values showed a difference of 10% or less compared to Fund Marks, and 43% of companies with ZX Index Values showed a difference of 20% or less compared to Fund Marks.

Heat Map: December 31st, 2024 Reporting Period

20.9%

Appreciation/Depreciation of All Reported Holdings1

3.1%

Average Mark-Up/Mark-Down Across All Reported Holdings2
Lightmatter
151.6%
Ripple
123.7%
Druva
87.8%
Prosper Marketplace
87.5%
xAI
80.9%
FourKites
69.2%
Caidya (dMed)
67.1%
SpaceX
65.2%
Centrexion
60.0%
Snorkel AI
56.6%
I-Pulse
49.3%
Kraken
45.3%
Nuro
44.0%
Tipalti
42.9%
Anchorage
41.2%
Checkr
41.2%
Motive (KeepTruckin)
37.9%
Impulse Dynamics
37.5%
Deepgram
35.9%
Cleerly
35.1%
Caris
32.9%
Tealium
30.8%
SambaNova
27.1%
Einride
26.5%
Dapper Labs
26.4%
Earnin
26.4%
Icertis
24.4%
Newfront Insurance
23.5%
Genesys
23.0%
Element Bio
22.5%
X Holdings
22.2%
Airtable
21.4%
Dataminr
20.7%
Underdog Fantasy
20.7%
Orchard
20.3%
PsiQuantum
20.2%
Illumio
19.9%
Unqork
19.8%
Superhuman
19.7%
Teya (SaltPay)
19.2%
FLEXE
19.0%
Trumid
19.0%
VAST Data
18.5%
EquipmentShare
18.1%
Moloco
17.9%
Canva
17.7%
Lambda Labs
17.7%
Retym
17.1%
YAP Therapeutics
16.6%
Aiven
16.4%
INRIX
16.2%
Anthropic
16.1%
Cybereason
16.1%
MNTN
15.9%
Rivos
15.6%
Anduril
15.3%
Bombas
15.2%
Figma
15.2%
ContentSquare
15.0%
Redwood Materials
15.0%
Devoted
14.9%
Eruditus
14.9%
InSilico
14.9%
Tarana
14.6%
Upgrade
14.2%
Skydio
13.6%
SingleStore
13.5%
Databricks
13.0%
GroundTruth
13.0%
Xsight Labs
13.0%
Celonis
12.6%
Patreon
12.5%
Grammarly
12.2%
CaaStle
11.8%
Coalition
11.7%
Acrisure
11.4%
Dragos
11.4%
Skyryse
11.3%
Asapp
11.0%
Cohere Technologies
11.0%
Cerebras
10.9%
SkySafe
10.6%
Versa Networks
10.2%
Zapp
9.5%
JumpCloud
8.9%
CoreWeave
8.8%
Arctic Wolf
8.6%
Tanium
8.3%
Whoop
7.9%
goPuff
7.5%
SiFive
7.4%
StormWind
7.2%
Fabletics
7.1%
Bolt
7.0%
Epic Games
6.8%
Fundbox
6.3%
Johnnie-O
6.1%
Apartment List
5.5%
Tebra (PatientPop)
5.5%
OpenAI
5.0%
Omada Health
4.8%
BETA Technologies
4.6%
Lime
4.5%
Snyk
4.5%
Gusto
4.3%
Tory Burch
4.3%
CloudBees
4.2%
RapidSOS
4.1%
Circle
4.0%
Applied Intuition
3.9%
Lookout
3.9%
Yotpo
3.8%
Collective Health
3.4%
Discord
3.2%
SmartHR
2.3%
Clear Labs
2.1%
StubHub
2.1%
Liquid Death
2.0%
OpenX
2.0%
Varo Money
2.0%
Locus Robotics
1.9%
Acronis
1.8%
Ocrolus
1.3%
Contrast Security
1.2%
Loadsmart
1.2%
Domino Data
1.0%
Betterment
0.9%
Klarna
0.9%
Trax
0.9%
Lyst
0.7%
ThoughtSpot
0.6%
Via Transportation
0.5%
Chime
0.4%
Stripe
0.4%
Astranis
0.3%
Verge Genomics
0.3%
Houzz
0.2%
Bytedance
0.1%
Nanotronics
0.1%
Waymo
0.1%
ADARx
0.0%
Aktis Oncology
0.0%
Anyscale
0.0%
Arbor Bio
0.0%
Arcadia
0.0%
ArsenalBio
0.0%
AtoB
0.0%
Avalyn Pharma
0.0%
BlueJay Therapeutics
0.0%
Brain Corp
0.0%
Cellanome
0.0%
ChromaCode
0.0%
Claris Bio
0.0%
ClassDojo
0.0%
Clio
0.0%
CNEX Labs
0.0%
Cohesity
0.0%
Compliable
0.0%
ConsenSys
0.0%
Cresta
0.0%
Curology
0.0%
DBT Labs
0.0%
Delfi
0.0%
Dialpad
0.0%
EndeavorBio
0.0%
FabFitFun
0.0%
Filevine
0.0%
FlashParking
0.0%
FogPharma
0.0%
Forum Brands
0.0%
Foursquare
0.0%
Freenome
0.0%
Frubana
0.0%
Generate Bio
0.0%
Genesis Therapeutics
0.0%
Happy Money
0.0%
HaulHub
0.0%
Hightouch
0.0%
Honor Tech
0.0%
Immuta
0.0%
Inscripta
0.0%
Insitro
0.0%
Invaio Sciences
0.0%
Jerry
0.0%
JUUL
0.0%
Kalderos
0.0%
Kandou
0.0%
Kardium
0.0%
Kartos Therapeutics
0.0%
KoBold Metals
0.0%
Laronde
0.0%
Lumicks
0.0%
Neon
0.0%
Nutcracker
0.0%
Obsidian Therapeutics
0.0%
Odyssey Therapeutics
0.0%
Overtime
0.0%
Pair Eyewear
0.0%
Passport
0.0%
PayJoy
0.0%
Plaid
0.0%
Ramp
0.0%
Rapyd
0.0%
RefleXion Medical
0.0%
Resilience
0.0%
Ring Therapeutics
0.0%
Savage X
0.0%
Scribe
0.0%
SecurityScorecard
0.0%
Sila Nano
0.0%
Sionna
0.0%
Socure
0.0%
Stash
0.0%
Tessera
0.0%
Third Arc Bio
0.0%
Thirty Madison
0.0%
Treeline Bio
0.0%
Turo
0.0%
Uniphore
0.0%
Vanta
0.0%
Verily
0.0%
Voyager Space
0.0%
WorkRise
0.0%
Zipline
0.0%
Automattic
-0.2%
Bright Machines
-0.2%
SirionLabs
-0.2%
Groq
-0.3%
Loft Orbital
-0.3%
OpenSpace
-0.3%
PrognomIQ
-0.3%
Tenstorrent
-0.3%
Envoy
-0.4%
NextRoll
-0.4%
Pine Labs
-0.4%
Sierra Space
-0.4%
Saluda Medical
-0.5%
ClearMotion
-0.6%
Click Therapeutics
-0.6%
GrubMarket
-0.6%
Bolt Financial
-0.7%
Medical Micro
-0.8%
Solugen
-0.8%
Color Genomics
-1.0%
Meesho
-1.2%
CelLink
-1.3%
Revolut
-1.4%
Ant Group
-1.5%
Hover
-1.5%
Diamond Foundry
-1.6%
Intercom
-1.6%
Omio
-1.6%
Aledade
-1.7%
DataRobot
-1.7%
CiBo
-1.8%
Lenskart
-1.8%
Automation Anywhere
-2.0%
Roofstock
-2.1%
Akeana
-2.2%
Clarify Health
-2.2%
Jumo
-2.7%
Validere
-2.7%
DataStax
-2.9%
Deep Instinct
-3.3%
Included Health (Grand Rounds)
-3.8%
Rappi
-3.8%
QuintoAndar
-4.0%
Breeze Airways
-4.2%
Alamar Bio
-4.6%
Farmers Business Network
-4.7%
Voltron Data
-4.9%
Docker
-5.2%
Essence Group
-5.2%
Lilac Solutions
-5.3%
Flexport
-5.5%
Attentive
-6.0%
Public
-6.2%
GOAT
-6.6%
Ursa
-6.6%
Carbon 3D
-6.7%
EverDrop
-6.8%
N26
-6.9%
SiMa ai
-7.0%
Algolia
-7.1%
AnyRoad
-7.1%
ElevateBio
-7.1%
Somatus
-7.3%
GupShup
-7.8%
DNA Script
-7.9%
Aspen Neuroscience
-8.2%
Enevate
-8.3%
Evozyne
-8.5%
Andpad
-8.7%
Moveworks
-9.0%
Noodle
-9.0%
Beta Bionics
-9.4%
Wagestream
-9.5%
Wugen
-9.7%
Lessen
-9.9%
Musely
-10.5%
BigID
-10.6%
MasterClass
-10.7%
Impossible Foods
-11.3%
Galvanize
-11.8%
Rad Power
-12.5%
ResearchGate
-13.0%
Cross River
-13.3%
Hearth
-13.6%
Blink Health
-13.7%
RealSelf
-13.9%
Course Hero
-14.2%
Leapwork
-14.8%
StockX
-15.4%
Axiom Space
-15.9%
Zocdoc
-16.6%
Outreach
-17.4%
Insight M
-18.4%
Pivot Bio
-18.4%
Fanatics
-18.5%
Minted
-18.6%
Contentful
-19.6%
Jetti Resources
-20.0%
IntelyCare
-20.2%
Lyra Health
-20.7%
Jeeves
-23.3%
Starling Bank
-25.3%
OfferUp
-27.6%
Evolve Vacation
-32.7%
Super73
-33.3%
Asimov
-33.6%
Prosimo
-34.2%
Verbit
-37.0%
WiTricity
-37.9%
Valo Health
-39.9%
Capsule
-41.8%
Magic Leap
-42.0%
Epirus
-43.3%
True Footage
-44.3%
Thriveworks
-45.9%
SalioGen
-50.0%
Source
-50.5%
Motif FoodWorks
-55.1%
Jetty
-64.8%
Carbon Health
-66.7%
Caresyntax
-71.2%
Eikon
-75.3%
Relativity Space
-82.7%
Exo Imaging
-97.0%
Binx Health
-100.0%

1 Dollar-weighted return on all reported holdings
2 Equal-weighted mark-up or mark-down across all reported holdings

This quarter, reporting holders marked up their private portfolios by 20.9% ($ weighted), the highest in over 5 years and mainly driven by large exposure to SpaceX across multiple funds. Reporting holders had an average mark-up of 3.1% (equal weighted).

Lightmatter experienced the most significant mark-up, followed by Ripple, Druva and Prosper Marketplace. Aerospace & Defense, SaaS and AI & Machine Learning saw the largest mark-ups across sectors.

Binx Health saw the largest mark-down followed by Exo Imaging, Relativity Space and Eikon. Among sectors, E-Commerce, HealthTech and EdTech saw the largest mark-downs.

Comparison of ZX Index Value vs. Fund Marks

CompaniesRobustness Score3ZX Index Values4 vs. Fund Marks
Skydio2+122.60%
Lime1+88.80%
Prosper Marketplace1+88.40%
Checkr1+83.00%
OpenAI4+81.80%
Lyra Health1+81.60%
GupShup2+73.00%
xAI8+64.50%
Whoop1+62.10%
Sila Nano2+60.60%
Anthropic7+51.20%
Docker1+51.10%
Blink Health2+49.90%
QuintoAndar2+46.90%
Socure1+43.50%
Aledade1+41.30%
CoreWeave7+35.90%
Ramp6+33.10%
Stripe8+31.30%
Cerebras5+29.00%
Yotpo2+27.20%
Meesho3+26.00%
Figma2+25.00%
Anduril4+24.60%
Carbon 3D2+15.30%
Celonis2+15.20%
Crusoe Energy3+14.40%
StockX1+13.50%
VAST Data4+11.70%
Chime6+9.90%
Perplexity AI4+7.70%
Thirty Madison2+7.10%
Airtable2+6.70%
Databricks6+6.50%
Cross River2+5.90%
Varo Money1+5.50%
Groq6+3.50%
Netskope5+2.90%
SpaceX8+2.90%
Epirus7+0.30%
Lambda Labs5+0.20%
Moveworks10.00%
Scale AI7-0.70%
Icertis1-0.80%
JUUL2-1.00%
Lyst1-1.70%
Canva1-1.90%
DataRobot1-2.10%
Klarna2-2.40%
Loadsmart1-2.90%
Cohesity5-4.90%
Algolia1-5.00%
Bolt1-5.30%
Waymo1-5.90%
Discord5-6.00%
Tenstorrent1-6.10%
Solugen1-6.50%
Loft Orbital2-8.60%
Dragos1-8.80%
Moloco1-8.90%
Plaid2-9.10%
Brex2-10.20%
Redwood Materials2-10.80%
Turo1-10.90%
Lightmatter2-11.00%
Circle6-11.20%
SandboxAQ6-11.40%
Axiom Space2-11.90%
Locus Robotics1-15.50%
Freenome2-16.30%
Anyscale1-16.70%
Illumio2-17.30%
Ursa6-18.40%
Liquid Death1-19.50%
Revolut2-19.80%
Omada Health1-21.10%
Attentive2-21.50%
SambaNova2-24.40%
SiFive1-24.60%
Arctic Wolf5-28.00%
Zipline6-28.70%
Fanatics2-29.20%
KoBold Metals2-31.00%
Somatus1-31.10%
Patreon1-31.80%
Flexport2-32.90%
Rapyd3-33.20%
Automation Anywhere1-33.90%
Epic Games6-34.10%
Deepgram1-34.20%
Upgrade2-35.20%
Gusto3-35.20%
Tanium2-36.20%
Bytedance7-36.70%
Outreach1-38.20%
Acronis1-39.10%
Snyk5-42.40%
Ripple6-43.60%
GrubMarket1-44.90%
MNTN1-47.60%
DBT Labs2-49.70%
SingleStore1-49.80%
Course Hero1-50.00%
EquipmentShare5-50.20%
Cybereason1-52.30%
Kraken7-52.50%
Druva1-55.90%
Via Transportation1-59.30%
Impossible Foods2-60.10%
Bolt Financial1-60.10%
Jeeves1-60.60%
Omio1-61.40%
Dataminr1-62.10%
PsiQuantum1-63.40%
Oura Health1-64.90%
Verbit1-75.30%
ThoughtSpot1-77.40%
CloudBees1-86.80%
Betterment1-91.20%

3 ZXData Robustness Score is an internally developed metric to assign confidence levels to the underlying data used in constructing ZXData output metrics. The ZXData Robustness Score is calculated on a scale of 1 to 10 for each company, based on the number of executed trades, number of buy and sell orders submitted to ZX and skewness of the order book.
4 ZX Index Value is an internally developed metric that reflects secondary values for private companies using an algorithmic approach based on the values sourced from ZX and ZXData partners. The algorithm used to calculate ZX Index Values incorporates both executed transaction values and bid and ask pricing.

In February, 27% of companies with ZX Index Values showed a difference of 10% or less compared to Fund Marks, and 43% of companies with ZX Index Values showed a difference of 20% or less compared to Fund Marks. Among the companies, Skydio, Lime, Checkr, and Prosper Marketplace had the highest positive variance in reported marks versus ZX Index Values. Betterment, CloudBees, ThoughtSpot and Verbit had the highest negative variance in reported marks versus ZX Index Values.

Highest Variance in Reported Marks
CompanyNormalized Std Dev5$ Weighted AvgMaxMin
Relativity Space2.11$3.46$22.67$0.02
Farmers Business Network1.39$4.39$38.54$1.86
Course Hero1.29$8.80$36.28$3.21
Curology.75$1.04$2.20$0.51
Rad Power.73$0.43$0.95$0.19

5 Normalized Standard Deviation is used to express the measure of spread across reported marks and allows for comparison between companies independent of their price per share based on a dollar-weighted average.

This period, Relativity Space ($0.02 - $22.67) saw the highest share price variance across funds followed by Farmers Business Network ($1.86 - $38.54) and Course Hero ($3.21 - $36.28).

Positive Trend Reversal6 (# = consecutive prior qtrs marked down or flat)
Negative Trend Reversal7 (# = consecutive prior qtrs marked up or flat)
Positive Trend Reversal6 (# = consecutive prior qtrs marked down or flat)
Caris, Celonis
13
Checkr, Element Bio
12
Airtable, Course Hero
11
I-Pulse, Nuro, Skyryse
11
Negative Trend Reversal7 (# = consecutive prior qtrs marked up or flat)
Eikon, True Footage
11
OfferUp
9
Hover
8
Relativity Space, Verge Genomics
7

6 Positive Trend Reversal reflects an individual holding marked up after consecutive quarterly periods marked down or flat
7 Negative Trend Reversal reflects an individual holding marked down after consecutive quarterly periods marked up or flat

Caris and Celonis saw their first positive reversal in thirteen quarters while Checkr and Element Bio saw their first positive reversal in twelve quarters. Eikon and True Footage saw their first negative reversal in eleven quarters while OfferUp saw its first negative reversals in nine quarters.

Disclaimer

This report is based on data reported by 300+ funds and $62+ billion of value. Many holders of private company shares do not report their holding values and are thus not included in this report’s dataset. Further, many venture-backed private companies are not held by any reporting funds and are thus not included in this report. As such, this report should not be construed as providing a complete picture of shareholder sentiment or venture-backed private company performance. This report does not constitute investment advice or a "research report" as defined by FINRA Rules.

The “ZX Index Value” is derived by applying proprietary weightings to the order flow data collected for the stated period (both bids and asks), based on the order type (firm order or indication of interest) and whether the order has been executed, with greater weight given to more recent orders.

Zanbato, Inc. (“Zanbato”) prepares and disseminates market information about venture-backed private company securities, and the current bids and offers for those securities listed on the ATS operated by Zanbato (“ZX”). The information provided in this report has been prepared by sales, trading, or other non-research functions. Pricing indications and macro commentary are provided for information purposes only. This report is not intended to assess the individual merits of a particular investment or strategy, does not constitute a recommendation to buy or sell any financial instrument or to participate in any trading strategy and should not be construed as such. This report does not constitute investment advice. Certain information in this report has been obtained from third party sources and, while such information is believed by Zanbato to be reliable, it has not been independently verified by Zanbato and Zanbato shall not be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with any use of, or reliance on, such third party information. Furthermore, the information contained in this report may not be current due to, among other things, changes in the financial markets or economic environment. Zanbato does not, and has no obligation to, update any such information contained in this report. Any prices or quotations contained herein are indicative only, do not represent firm quotes as to either price or size and should not be used for valuation purposes.

yukacon_arrow_up_right